Zambia praised for participating in HIV research
WE are delighted that Zambia is taking part in issues of global HIV research in fighting the disease on the African continent, says Treatment, Advocacy and Literacy Campaign, (TALC) executive director Felix Mwanza. Mr Mwanza said all HIV and AIDS interventions should be backed by scientific research and it was delightful that Africa had joined in finding solutions for global health problems. He said it was not only Western countries that should be involved in HIV/AIDS scientific research but that all nations including African countries must participate. “We welcome this gesture and would also like to congratulate Zambia Emory HIV Research Project (ZEHRP) and the Centre for Infectious Disease Research in Zambia (CIDRZ) for granting this mission to undertake this trial,” he said. Earlier in the week, National Biosafety Authority (NBA) announced that Zambia had approved clinical trials for another HIV-vaccine to prevent infection in women. NBA chief executive officer Lackson Tonga disclosed that about 500 participants aged between 18-35 years had been identified across places in Zambia, South Africa, Mozambique, Zimbabwe and Malawi through ZEHRP and CIDRZ as subjects for the trial.